title: Cardiovascular effects of pipecuronium and pancuronium in patients undergoing coronary artery bypass grafting.
authors.affiliation: Department of Anesthesiology, University Hospital, Geneva, Switzerland.
authors.forename: E
authors.initials: E
authors.lastname: Tassonyi
authors.forename: P
authors.initials: P
authors.lastname: Neidhart
authors.forename: J F
authors.initials: JF
authors.lastname: Pittet
authors.forename: D R
authors.initials: DR
authors.lastname: Morel
authors.forename: M
authors.initials: M
authors.lastname: Gemperle
mesh_terms: D000368:Aged; D015113:Androstane-3,17-diol / Q000009:adverse effects* / Q000031:analogs & derivatives; D000732:Androstanols / Q000009:adverse effects*; D001919:Bradycardia / Q000139:chemically induced*; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass; D006801:Humans; D007022:Hypotension / Q000139:chemically induced*; D008875:Middle Aged; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects*; D010197:Pancuronium / Q000009:adverse effects*; D017300:Pipecuronium; D010879:Piperazines / Q000009:adverse effects*; D011897:Random Allocation
chemical_list: D000732:Androstanols; D009466:Neuromuscular Blocking Agents; D010879:Piperazines; D017300:Pipecuronium; D015113:Androstane-3,17-diol; D010197:Pancuronium